Description
Composition- Sacubitril 49 mg + Valsartan 51 mg
Mode of Action- Combines neprilysin inhibition with angiotensin receptor blockade to reduce cardiac stress, improve natriuresis and support heart failure management.
USPs- Evidence-based heart failure support; improves cardiovascular hemodynamics; dual neurohormonal modulation.
Prescribing Specialties- Cardiologist, Internal Medicine
